Amtech Systems is a manufacturer of capital equipment. The company's segments include: Semiconductor, which supplies thermal processing equipment, including solder reflow ovens, diffusion furnaces, and customer high-temp belt furnaces for use by semiconductor and electronics assembly manufacturers; Silicon Carbide/Light-Emitting Diodes, which produces substrate consumables and machinery for lapping (fine abrading) and polishing of materials, such as silicon wafers and sapphire wafers; and Automation, which supplies semiconductor and solar automation with in-house design and manufacturing capabilities and provides single wafer transfer tools as well as batch transfer tools and stocker options.

Beyond Air is a medical device company developing a nitric oxide (NO) generator and delivery system (the Beyond Air NOGDS) that is capable of generating NO from ambient air. The Beyond Air NOGDS can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. The company's initial areas of focus are persistent pulmonary hypertension of the newborn (PPHN), bronchiolitis and nontuberculous mycobacteria. With respect to PPHN, the company's Beyond Air NOGDS is designed to deliver a dosage of low-concentration of NO to the lungs. The company's Beyond Air NOGDS can also deliver a high concentration of NO to the lungs.

Cyanotech is engaged in the production of natural products derived from microalgae. The company's products include: Hawaiian BioAstin? natural astaxanthin, a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to improve skin, and to support eye and joint health; and Hawaiian Spirulina Pacifica?, a dietary supplement used for extra energy, immune system, cardiovascular benefits and as a source of antioxidant carotenoids. The company operates in one operating segment, the cultivation and production of microalgae into natural health and nutrition products.

Enterprise Products Partners is a provider of midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals and refined products. The company's midstream energy operations include: natural gas gathering, treating, processing, transportation and storage; NGL transportation, fractionation, storage, and export and import terminals; crude oil gathering, transportation, storage, and export and import terminals; petrochemical and refined products transportation, storage, export and import terminals, and related services; and a marine transportation business that operates primarily on the U.S. inland and Intracoastal Waterway systems.

First Merchants is a financial holding company. Through its subsidiary, First Merchants Bank (the Bank), the company provides a range of financial services, including accepting time, savings and demand deposits; making consumer, commercial, agri-business and real estate mortgage loans; providing personal and corporate trust services; providing brokerage and private wealth management; and providing letters of credit, repurchase agreements and other services. The Bank also operates First Merchants Private Wealth Advisors (a division of the Bank). The Bank includes banking locations in Indiana, Illinois, Ohio and Michigan counties. The company provides electronic and mobile delivery channels to its customers.

Verrica Pharmaceuticals is a dermatology therapeutics company focused on the development and commercialization of treatments for people living with skin diseases. The company's primary product candidate, VP-102, is a proprietary drug-device combination of its topical solution of cantharidin, a naturally sourced agent to treat topical dermatological conditions, administered through its single-use precision applicator. The company is initially developing VP-102 for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. In addition, the company is also developing VP-102 for the treatment of external genital warts.